Satellos to Participate in Upcoming Investor Conferences
Financial Post ·
TORONTO, Oct. 21, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage company developing potentially life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in November. Guggenheim 3rd Annual Healthcare Innovation ConferenceDate: Monday, Nov. 9, 2026Fireside Chat: 9:30 a.m. ETLocation: Boston, MAWebcast […]
Read More